Treatment period and changes in bone markers according to the application of teriparatide in treating medication-related osteonecrosis of the jaw
TPTD administration during MRONJ treatment potentially reduces the need for surgical intervention and accelerates recovery, significantly affecting bone metabolism. These findings highlight TPTD's role in enhancing the efficacy of MRONJ treatment. TPTD could potentially offer the dual benefit of promoting bone healing and reducing the need for surgical intervention, thus improving overall outcomes for patients with MRONJ.
Authors
- Hyung Jun Kim (ORCID: https://orcid.org/0000-0001-8247-4004)
- Young‐Soo Jung (ORCID: https://orcid.org/0000-0001-5831-6508)
- Jin Hoo Park
- Wonse Park (ORCID: https://orcid.org/0000-0002-2081-1156)
- S. H. Cho (ORCID: https://orcid.org/0009-0008-7948-7419)
- Jin‐Woo Kim (ORCID: https://orcid.org/0000-0002-1672-5730)
- Jun‐Young Kim (ORCID: https://orcid.org/0000-0002-6596-6135)
- Hyunmi Jo (ORCID: https://orcid.org/0000-0001-5186-0834)
- Loi Phuoc Nguyen (ORCID: https://orcid.org/0009-0007-9369-5102)
Institutions
- Ewha Womans University (KR)
- Yonsei University (KR)
- University of Medicine and Pharmacy at Ho Chi Minh City (VN)
- Yonsei University Health System (KR)
- Yonsei University College of Dentistry
Publication Details
- Journal
- BMC Oral Health
- Published
- 2025-04-11
- DOI
- https://doi.org/10.1186/s12903-025-05867-w
- Citations
- 4
- Primary Topic
- Bone health and treatments
- Type
- article
- Field-Weighted Citation Impact
- 4.18